Adverum Biotechnologies (NASDAQ:ADVM) Posts Earnings Results, Misses Estimates By $0.01 EPS

Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) announced its quarterly earnings data on Tuesday. The biotechnology company reported ($0.35) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.34) by ($0.01), MarketWatch Earnings reports. Shares of NASDAQ ADVM opened at $1.34 on Thursday. Adverum Biotechnologies has a twelve month low of $1.21 and a twelve […]

Related Keywords

Steven Daniel Schwartz ,Marks Blumenkranz ,Thomasw Chalberg Jr ,Adverum Biotechnologies Inc ,Wells Fargo Company ,Zacks Investment Research ,Mission Capital ,Millennium Management ,Barclays Plc ,Invesco Ltd ,Adverum Biotechnologies ,Get Rating ,Marketwatch Earnings ,Investment Research ,Redwood City ,Nasdaq Advm ,Advm ,Medical ,Earnings ,